Can cortisol signaling affect thyroid regulation?

The claim is supported: HPA-axis glucocorticoid signaling can modulate thyroid regulation centrally and peripherally, with the most direct human evidence for suppression of TSH secretion.

Clinical and endocrine evidence

• In healthy adults, dexamethasone 16 mg/day for 2.5 days reduced basal TSH from 2.2 to 0.8 μU/mL and reduced peak TRH-stimulated TSH from 16.4 to 5.8 μU/mL. Earlier studies found cortisol or dexamethasone reduced TSH to 18–47% of baseline within 8–12 hours.
• In Cushing syndrome, chronic endogenous cortisol excess suppresses thyroid-axis activity: among 63 patients, 54% had markedly blunted TRH-stimulated TSH responses, which improved after treatment. Pulsatile TSH secretion is also reduced during active disease.
• The response depends on exposure context. For example, an acute high-dose hydrocortisone infusion did not alter basal or TRH-stimulated TSH in healthy participants. TSH therefore should be interpreted with cortisol status, thyroid hormone values, illness, and medications in mind.

Mechanistic and peripheral effects

• Glucocorticoid receptors on hypothalamic TRH-producing neurons and reduced paraventricular-nucleus Trh expression during chronic glucocorticoid excess support reduced hypothalamic TRH drive. At the pituitary, glucocorticoids reduce thyrotroph TSH secretion and responsiveness to TRH.
• Small controlled human studies show dexamethasone lowers T3 and raises reverse T3 without materially changing T4. This occurred in athyreotic people receiving T4 replacement and when TSH was already suppressed by oral T4, supporting altered extrathyroidal hormone handling rather than reduced thyroid secretion.
• The likely process is a shift in deiodination away from T4-to-T3 activation and toward reverse-T3–associated inactivation, although the responsible human tissues and deiodinase isoforms remain unestablished.

Bottom line

• Altered cortisol signaling—especially substantial or sustained glucocorticoid excess—can suppress TSH and shift peripheral thyroid-hormone metabolism toward lower T3 and higher reverse T3. These biochemical changes do not, by themselves, establish primary thyroid disease.